S. Chaudhary

Best supportive care compared with chemotherapy for unresectable gall bladder cancer: a randomized controlled study.

V. Sreenivas, P. Garg, B. Mohanti, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Lactobacillus brevis CD2 lozenges reduce radiation- and chemotherapy-induced mucositis in patients with head and neck cancer: a randomized double-blind placebo-controlled study.

B. Mohanti, A. Thakar, G. Rath, 2012, European journal of cancer.

Revisiting MET: Clinical Characteristics and Treatment Outcomes of Patients with Locally Advanced or Metastatic, MET-Amplified Esophagogastric Cancers.

Jeffrey W. Clark, A. Iafrate, C. Azzoli, 2020, The oncologist.

Immunoproliferative small intestinal disease: a report of 6 cases.

G. Makharia, S. Arava, Atul Sharma, 2014, Tropical gastroenterology : official journal of the Digestive Diseases Foundation.

Lactobacillus brevis CD2 lozenges prevent oral mucositis in patients undergoing high dose chemotherapy followed by haematopoietic stem cell transplantation

R. Sahoo, V. Raina, L. Kumar, 2016, ESMO Open.

A phase 2 clinical trial of the heat shock protein 90 (HSP 90) inhibitor ganetespib in patients with refractory advanced esophagogastric cancer

Jeffrey W. Clark, W. Goessling, R. Heist, 2020, Investigational New Drugs.

465 Bintrafusp alfa in combination with chemotherapy in patients with stage IV NSCLC: safety and pharmacokinetic results of the INTR@PID LUNG 024 study

Y. Vugmeyster, C. Rolfo, F. Ghiringhelli, 2021, Journal for ImmunoTherapy of Cancer.